Letsch A - Search Results

1

Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome.

Löbel M, Mooslechner AA, Bauer S, Günther S, Letsch A, Hanitsch LG, Grabowski P, Meisel C, Volk HD, Scheibenbogen C. Löbel M, et al. Among authors: letsch a. J Transl Med. 2015 Aug 14;13:264. doi: 10.1186/s12967-015-0628-4. J Transl Med. 2015. PMID: 26272340 Free PMC article.

2

Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.

Asemissen AM, Nagorsen D, Keilholz U, Letsch A, Schmittel A, Thiel E, Scheibenbogen C. Asemissen AM, et al. Among authors: letsch a. J Immunol Methods. 2001 May 1;251(1-2):101-8. doi: 10.1016/s0022-1759(01)00312-x. J Immunol Methods. 2001. PMID: 11292486

3

Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptides.

Scheibenbogen C, Nagorsen D, Seliger B, Schmittel A, Letsch A, Bauer S, Max N, Bock M, Atkins D, Thiel E, Keilholz U. Scheibenbogen C, et al. Among authors: letsch a. Int J Cancer. 2002 May 20;99(3):403-8. doi: 10.1002/ijc.10328. Int J Cancer. 2002. PMID: 11992409

4

Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.

Nagorsen D, Scheibenbogen C, Schaller G, Leigh B, Schmittel A, Letsch A, Thiel E, Keilholz U. Nagorsen D, et al. Among authors: letsch a. Int J Cancer. 2003 Jun 10;105(2):221-5. doi: 10.1002/ijc.11052. Int J Cancer. 2003. PMID: 12673683

5

Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining.

Letsch A, Scheibenbogen C. Letsch A, et al. Methods. 2003 Oct;31(2):143-9. doi: 10.1016/s1046-2023(03)00124-5. Methods. 2003. PMID: 12957572 Review.

6

Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells.

Letsch A, Keilholz U, Assfalg G, Mailänder V, Thiel E, Scheibenbogen C. Letsch A, et al. Cancer Res. 2003 Sep 1;63(17):5582-6. Cancer Res. 2003. PMID: 14500398

7

Rational peptide-based tumour vaccine development and T cell monitoring.

Scheibenbogen C, Letsch A, Schmittel A, Asemissen AM, Thiel E, Keilholz U. Scheibenbogen C, et al. Among authors: letsch a. Semin Cancer Biol. 2003 Dec;13(6):423-9. doi: 10.1016/j.semcancer.2003.09.006. Semin Cancer Biol. 2003. PMID: 15001161 Review.

8

Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.

Keilholz U, Goldin-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A, Scheibenbogen C, Heufelder K, Eggermont A, Thiel E. Keilholz U, et al. Among authors: letsch a. Clin Cancer Res. 2004 Mar 1;10(5):1605-12. doi: 10.1158/1078-0432.ccr-0610-3. Clin Cancer Res. 2004. PMID: 15014010

9

Functional CCR9 expression is associated with small intestinal metastasis.

Letsch A, Keilholz U, Schadendorf D, Assfalg G, Asemissen AM, Thiel E, Scheibenbogen C. Letsch A, et al. J Invest Dermatol. 2004 Mar;122(3):685-90. doi: 10.1111/j.0022-202X.2004.22315.x. J Invest Dermatol. 2004. PMID: 15086554 Free article.

10

Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients.

Letsch A, Keilholz U, Fluck M, Nagorsen D, Asemissen AM, Schmittel A, Thiel E, Scheibenbogen C. Letsch A, et al. Int J Cancer. 2005 May 10;114(6):936-41. doi: 10.1002/ijc.20819. Int J Cancer. 2005. PMID: 15645483 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters